Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Resmed Inc
(NY:
RMD
)
222.21
+1.94 (+0.88%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Resmed Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Why ResMed Stock Is Jumping Today
January 25, 2024
The medical device maker beat expectations with its latest quarterly results.
Via
The Motley Fool
ResMed Flexes Its Operating Muscle, Sends Shares Flying Above Their 200-Day Line
January 25, 2024
ResMed reported better-than-expected sales and adjusted earnings.
Via
Investor's Business Daily
AT&T To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Thursday
January 25, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Recap: ResMed Q2 Earnings
January 24, 2024
Via
Benzinga
3 Stocks to Buy to Benefit From the Booming Sleep Industry
January 23, 2024
It’s not easy to find sleep stocks to buy despite the fact the industry is booming these days from society's lack of rest and relaxation.
Via
InvestorPlace
FDA Identifies ResMed's Recall Of Certain Ventilator Device Masks With Magnets As Most Serious
January 12, 2024
ResMed (NYSE: RMD) recalls certain respiratory masks with magnets due to potential interference with medical devices. FDA Class I recall.
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
If You Invested $100 In This Stock 15 Years Ago, You Would Have $900 Today
January 10, 2024
Via
Benzinga
Demystifying ResMed: Insights From 5 Analyst Reviews
January 09, 2024
Via
Benzinga
Earnings Scheduled For January 24, 2024
January 24, 2024
Companies Reporting Before The Bell • Freeport-McMoRan (NYSE:FCX) is estimated to report quarterly earnings at $0.22 per share on revenue of $5.86 billion.
Via
Benzinga
ResMed's Earnings: A Preview
January 23, 2024
Via
Benzinga
Why NYSE:RMD provides a good dividend, while having solid fundamentals.
January 17, 2024
Exploring RESMED INC (NYSE:RMD)'s dividend characteristics.
Via
Chartmill
Uncovering Dividend Opportunities with NYSE:RMD.
December 26, 2023
Why RESMED INC (NYSE:RMD) qualifies as a good dividend investing stock.
Via
Chartmill
Top Picks 2024: ResMed
January 07, 2024
ResMed is the market leader in continuous positive airway pressure machines. ResMed has enjoyed a steadily growing market throughout its history, and investors have often paid sky-high valuations for...
Via
Talk Markets
$1000 Invested In ResMed 15 Years Ago Would Be Worth This Much Today
December 25, 2023
Via
Benzinga
(RMD) - Analyzing ResMed's Short Interest
December 22, 2023
Via
Benzinga
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $17,000 Today
December 14, 2023
Via
Benzinga
Why NYSE:RMD qualifies as a good dividend investing stock.
November 30, 2023
Is RESMED INC (NYSE:RMD) a Good Fit for Dividend Investing?
Via
Chartmill
Senator's Bearish Tesla Bet Under Scrutiny As He Buys Put Options Ahead Of Elon Musk-Led Company's Q3 Results That Set Stock Slide In Motion
November 17, 2023
Sen. Tommy Tuberville bought 3 tranches of put options to sell Tesla shares at $190 a day ahead of Q3 results that set in motion a stock slump.
Via
Benzinga
Why the dividend investor may take a look at NYSE:RMD.
November 08, 2023
Analyzing RESMED INC (NYSE:RMD)'s Dividend Potential.
Via
Chartmill
Is NYSE:RMD a Good Fit for Dividend Investing?
October 18, 2023
Analyzing RESMED INC (NYSE:RMD)'s Dividend Potential.
Via
Chartmill
2 Monster Stocks to Buy Without Any Hesitation
November 07, 2023
Down 33% and 44%, these two stocks look too good to pass up today.
Via
The Motley Fool
How Sleep Device Player ResMed Is Gaining Philips' Market Share In Flow Generator Market - Analysts Weigh In
October 27, 2023
Needham analyst Mike Matson reiterated a Buy rating on ResMed Inc. (NYSE: RMD)
Via
Benzinga
Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?
October 27, 2023
Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story.
Via
Investor's Business Daily
3 Stocks to Buy From the ‘Buy the Dip’ ETF
October 23, 2023
It’s a lot harder than it looks to buy the dip. Using artificial intelligence to do this makes these three stocks a buy.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Expert Ratings for ResMed
October 12, 2023
Via
Benzinga
Earnings Scheduled For October 26, 2023
October 26, 2023
Companies Reporting Before The Bell • TotalEnergies (NYSE:TTE) is likely to report quarterly earnings at $2.57 per share on revenue of $49.83 billion.
Via
Benzinga
Exxon Mobil To Rally Around 23%? Here Are 10 Other Analyst Forecasts For Thursday
October 12, 2023
Cantor Fitzgerald cut Hyliion Holdings Corp. (NYSE: HYLN) price target from $2 to $1. Cantor Fitzgerald analyst Andres Sheppard downgraded the stock from Neutral to Underweight. Hyliion shares fell...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2023
October 12, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
September 18, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023
September 29, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.